BEGIN:VCALENDAR
PRODID:-//Microsoft Corporation//Outlook 15.0 MIMEDIR//EN
VERSION:2.0
METHOD:PUBLISH
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VTIMEZONE
TZID:Eastern Standard Time
BEGIN:STANDARD
DTSTART:16011104T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:16010311T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
CLASS:PUBLIC
CREATED:20200212T201400Z
DESCRIPTION:Residual LCP After Stenting? Using NIRS to Assess the Risk of T
arget Lesion Failure\nRYAN MADDER\, MD\n\n30 Minute discussion by Dr. Madd
er followed by a 30 minute hands-on demo of the Makoto Intravascular Imagi
ng System in the Infraredx\, a Nipro Company\, Learning Center #9\n\n
DTEND;TZID="Eastern Standard Time":20200223T110000
DTSTAMP:20200212T201400Z
DTSTART;TZID="Eastern Standard Time":20200223T103000
LAST-MODIFIED:20200212T201400Z
LOCATION:CRT 2020: Infraredx\, a Nipro Company Learning Center 9
PRIORITY:5
SEQUENCE:0
SUMMARY;LANGUAGE=en-us:Infraredx\, a Nipro Company Didactic Session: Residu
al LCP After Stenting? Using NIRS to Assess the Risk of Target Lesion Fail
ure with Dr. Ryan Madder
TRANSP:OPAQUE
UID:040000008200E00074C5B7101A82E008000000004092FF3BB6E1D501000000000000000
010000000CA8ABFE9CD00D941BD9A22697DA00B49
X-ALT-DESC;FMTTYPE=text/html:\n\n\n\n\n\n\n\n\nResidual LCP After Stenting? Using NIRS to Assess the Risk of Target
Lesion Failure
\nRYAN MADDER\, MD
\n\n30 Minute discussion by Dr. Madder foll
owed by a 30 minute hands-on demo of the Makoto Intravascular Imaging System in the Infraredx\
, a Nipro Company\, Learning Center #9
\n\n
\n\n\n
X-MICROSOFT-CDO-BUSYSTATUS:BUSY
X-MICROSOFT-CDO-IMPORTANCE:1
X-MICROSOFT-DISALLOW-COUNTER:FALSE
X-MS-OLK-AUTOFILLLOCATION:FALSE
X-MS-OLK-CONFTYPE:0
BEGIN:VALARM
TRIGGER:-PT15M
ACTION:DISPLAY
DESCRIPTION:Reminder
END:VALARM
END:VEVENT
END:VCALENDAR